Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (4): 540-544    DOI: 10.12891/ceog3461.2017
Original Research Previous articles | Next articles
Does gestational weight gain of more than 12 kg in women increase the risk of a cesarean section delivery, gestational diabetes and pregnancy induced hypertension? A retrospective case series
A. Antonakou1, *(), D. Papoutsis2, A. Kechagia3
1 Midwifery School, ‘Alexander’ Technological Educational Institute of Thessaloniki, Thessaloniki, Greece
2 Shrewsbury and Telford Hospital, NHS Trust, Shropshire, UK
3 Independent Practice Midwifery, Ptolemaida, Greece
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  Purpose: The purpose of this study was to investigate whether the gestational weight gain of more than 12 kg represented a risk factor for an increased rate of cesarean section (CS) delivery, gestational diabetes, and pregnancy-induced hypertension (PIH). Materials and Methods: This was a retrospective case series study performed in a Greek National Health Service hospital and included women having given birth to singleton pregnancies between 2004-2009. Cases with multiple pregnancies, stillbirths, and congenital fetal abnormalities were excluded. Results: 600 eligible women were included in the study. Gestational weight increase correlated positively and was higher in women with a CS delivery, gestational diabetes, and PIH. The prepregnancy body mass index was identified as a predictor of gestational diabetes. The weight gain of less than 12 kg during pregnancy provided a protective effect against CS delivery by reducing the likelihood of this by 85%. Conclusion: The present authors have shown that the increased body weight gain during pregnancy of more than 12 kg is associated with increased rates of CS delivery, gestational diabetes, and hypertensive disorders in pregnancy.
Key words:  Body mass index      Cesarean section      Gestational diabetes      Preeclampsia     
Published:  10 August 2017     
*Corresponding Author(s):  A. ANTONAKOU     E-mail:  angelantonakou@gmail.com

Cite this article: 

A. Antonakou, D. Papoutsis, A. Kechagia. Does gestational weight gain of more than 12 kg in women increase the risk of a cesarean section delivery, gestational diabetes and pregnancy induced hypertension? A retrospective case series. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 540-544.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3461.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I4/540

[1] H.M. Kim, Y.S. Choo, W.J. Seong. Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 511-515.
[2] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[3] J. A. Villarreal-Rodriguez, L. G. Mancillas Adame, J. Maldonado-Sanchez, A. Guzmán-López, O. R. Treviño-Montemayor, J. G. Gonzalez-Gonzalez, D. Saldívar-Rodríguez. A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 552-555.
[4] A.M. Sindiani, H.M. Rawashdeh, E.H. Alshdaifat, O.F. Altal, H. Yaseen, A.A. Alhowary. The association between repeated doses of vaginal PGE2 (Dinoprostone, Prostin®) and both maternal and neonatal outcomes among women in the north of Jordan[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 329-334.
[5] F. Wang, Z.X. Liang, W.R. Mao, S.N. He, D.Q. Chen. Influence of pre-pregnancy body mass index and gestational weight gain in twin pregnancies on blood glucose, serum lipid and perinatal outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 376-382.
[6] H.J. Wang, T.H. Chou, Y.C. Lee, H.K. Au. Acute fatty liver during pregnancy and gestational diabetes insipidus: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 438-441.
[7] A.E. Kholeif, M.Y. Khamis, S. Eltabakh, R.S. Swilam, A. Elhabashy, R. EISherif. Prediction of severity of preeclampsia in Egyptian patients: role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and C-reactive protein[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 183-188.
[8] J. Huang, Z. Zhang. Spontaneous umbilical cord vascular rupture before labor for congenital defects with a live birth: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 142-143.
[9] K. Relakis, A. Pontikaki, I. Kosmas, S. Sifakis. Bilateral ascending uterine arteries ligation for conservative management of complete placenta previa: three case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 144-146.
[10] H. Takahashi, Y. Baba, M. Ogoyama, H. Suzuki, A. Ohkuchi, R. Usui, S. Matsubara. Does previous cesarean section per se, especially its number, increase the risk of allogeneic blood transfusion at cesarean section for placenta previa?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 41-46.
[11] K.Y. Yun, S.Y. Hwang, H.J. Lee, S.C. Kim, J.K. Joo, D.S. Suh, K.H. Kim, K.S. Lee. The association of body mass index with incidence, stage and recurrence of endometriosis: case-control study in Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 53-56.
[12] Hongying Zhang, Qingling Wei, Jinlan Wei, Haiyang Pang, Wenxuan Wei, Yu Sun, Mengya He, Yanling Sun. Importance of diagnosis time on pregnancy outcomes in pregnant women with pre-gestational diabetes mellitus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 57-61.
[13] H. Kiyak, L. S. Turkgeldi, C. Ozdemir, S. Gunkaya, K. Tolga, A. Gedikbası. Myomectomy during cesarean section: is it a redundant or a feasible procedure?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 881-887.
[14] A. Basha, Z. Falayleh, R. Jabra, S. Attili, Y. Obeidat, L. El-Khatib, A. Ala’eddien Obeidat. Cesarean section: Where are we are now? A comparative study between 1997-1998 and 2015-2016 at a tertiary teaching hospital in a developing country[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 943-947.
[15] G. Virdis, F. Dessole, A. Andrisani, A. Vitagliano, R. Cappadona, G. Capobianco, E. Cosmi, G. Ambrosini, S. Dessole. Cesarean scar pregnancy: a report of three cases and a critical review on the management[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 982-985.
No Suggested Reading articles found!